Compositions And Methods For Inhibiting Expression Of GSK-3 Genes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160024497A1
SERIAL NO

14698109

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting Glycogen Synthase Kinase-3 (GSK-3), and methods of using the dsRNA to inhibit expression of GSK-3.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALNYLAM PHARMACEUTICALS INC300 THIRD STREET 3RD FLOOR CAMBRIDGE MA 02142

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hinkle, Gregory Plymouth, US 164 786
Sah, Dinah Wen-Yee Boston, US 85 907

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation